Elsevier,
Rehabilitation Robots for Neurorehabilitation in High-, Low-, and Middle-Income Countries
Current Practice, Barriers, and Future Directions
2024, Pages 471-498
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by raising the general and ethical issues around access to rehabilitation robot technologies and discusses them in the context of inclusivity—a term that encompasses affordability and other common issues that may justify limiting or increasing use in low-resource settings in HICs and LMICs.
Elsevier,
Rehabilitation Robots for Neurorehabilitation in High-, Low-, and Middle-Income Countries: Current Practice, Barriers, and Future Directions, 2024, Pages 167-178
This content aligns with Goal 3: Good Health by addressing the urgent healthcare challenges posed by Japan's aging population, particularly regarding physical disabilities and the increasing demand for effective rehabilitation and care solutions. The exploration of robotics and innovative technologies in stroke rehabilitation not only aims to enhance the quality of life for individuals with disabilities but also seeks to improve overall health outcomes. Additionally, it aligns with Goal 10: Reduced Inequalities by highlighting the importance of accessible and inclusive healthcare solutions, such as telerehabilitation and community-based integrated care systems, which can help ensure that older adults and individuals with disabilities receive equitable support and resources regardless of their circumstances.
This content aligns with Goal 3: Good Health by critically evaluating the efficacy of prodrugs in treating attention-deficit hyperactivity disorder (ADHD) and binge-eating disorder (BED), highlighting the importance of optimizing pharmacokinetic and pharmacodynamic properties to ensure effective and safe management of these conditions. By focusing on the therapeutic benefits and potential side effects of medications like lisdexamfetamine and serdexmethylphenidate, the review underscores the need for tailored treatment strategies that can improve health outcomes for individuals affected by these disorders. Additionally, it supports Goal 10: Reduced Inequalities by addressing the importance of accessible and effective medication options for ADHD and BED, ensuring that all patients, regardless of their background, have the opportunity to receive appropriate care and resources to manage their conditions effectively while minimizing the risk of misuse and abuse.
Elsevier,
Diagnostic Molecular Pathology (Second Edition): A Guide to Applied Molecular Testing, 2024, Pages 63-77
This content aligns with Goal 3: Good Health by summarizing the current molecular methods of detection and quantification of hepatitis virus genomes, with special emphasis on the assays commercially available and applicable for clinical use.
Elsevier,
Clinician's Guide to Sexuality and Autism
A Guide to Sex Education for Individuals with Autism Spectrum Disorders
2024, Pages 3-8
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by introducing sexuality education curriculum for learners of all ages with autism.
Elsevier,
Clinician's Guide to Sexuality and Autism
A Guide to Sex Education for Individuals with Autism Spectrum Disorders
2024, Pages 9-16
This content aligns with Goal 3: Good Health and Wellbeing and Goal 10: Reduced Inequalities by outlining how to use the book to provide effective teaching in sexuality education with an emphasis on individualization for specific learners.
This content aligns with Goal 3: Good Health and Wellbeing by presenting the current evidence for HIV/AIDS prevention.
This content aligns with Goal 3: Good Health and Wellbeing as well as Goal 10: Reduced Inequalities by providing information about access to evidence-based treatment and prevention interventions as well as addressing the underlying social, political and economic issues, such as poverty, lack of access to healthcare, and stigma and discrimination that contribute to the high burden of HIV in the region
With a pressing climate emergency and increasing interconnectedness, the need for action on health at a global level is greater than ever. Achieving Universal Health Coverage with a strong base in primary healthcare is essential. This must be accompanied by policies to address the socioeconomic and environmental determinants of ill health, supporting SDG3.
This content aligns with Goal 3: Good Health proving that viral hepatitis is increasing as a global challenge, in contrast to other major infectious causes of death (e.g. tuberculosis (TB), HIV, and malaria).
